Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria

NCT02191072 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Urticaria

Interventions

DRUG: omalizumab

Sponsor

National Taiwan University Hospital